JL

Jing Liu

IS Icahn School Of Medicine At Mount Sinai: 2 patents #3 of 55Top 6%
TS Tarapeutics Science: 2 patents #1 of 21Top 5%
IT Indiana University Research And Technology: 1 patents #3 of 55Top 6%
UH University Of North Carolina At Chapel Hill: 1 patents #22 of 188Top 15%
TT Turning Point Therapeutics: 1 patents #1 of 10Top 10%
📍 Oradell, NJ: #1 of 9 inventorsTop 15%
🗺 New Jersey: #133 of 6,455 inventorsTop 3%
Overall (2024): #14,388 of 561,600Top 3%
8
Patents 2024

Issued Patents 2024

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
12162876 Indazole kinase inhibitor and use thereof Qingsong LIU, Xuesong Liu, Beilei Wang, Cheng-Yu Chen, Ziping Qi +6 more 2024-12-10
12115152 Pan-RAF kinase inhibitor and use thereof Qing Liu, Xi Li, Ao WANG, Zi Ping Qi, Qing Liu +6 more 2024-10-15
12115158 Survivin-targeting anti-tumor agents and uses thereof Jian Zhang, Mingji Dai 2024-10-15
12110295 WD40 repeat domain protein 5 (WDR5) degradation/disruption compounds and methods of use Jian Jin, Gang Wang, Xufen Yu, Dongxu Li 2024-10-08
12103924 Mitogen-activated protein kinase kinase (MEK) degradation compounds and methods of use Jian Jin, Jianping Hu, Jieli Wei, Hyerin Yim, Md Kabir 2024-10-01
12065442 Tropomyosin receptor kinase (TRK) degradation compounds and methods of use Liqun CHEN 2024-08-20
11981684 Macrocyclic compounds and uses thereof Jingrong Jean Cui, Evan Rogers, Jane Ung, Jeffrey P. Whitten, Dayong Zhai +4 more 2024-05-14
11969472 Tropomyosin receptor kinase (TRK) degradation compounds and methods of use Jialiang Wang, Xiaoran HAN, Liqun CHEN 2024-04-30